Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Journal of the National Cancer Institute|April 19, 1989
Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell lineR D Bonfil, R R Reddel, H Ura, et al.Cancer Research|April 1, 1996
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancerD J Grignon, W Sakr, M Toth, et al.The Journal of Biological Chemistry|January 25, 2000
Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1M W Olson, M M Bernardo, M Pietila, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancerB Schmalfeldt, D Prechtel, K Härting, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and gradeF J Bianco, D C Gervasi, R Tiguert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasiaJ Upadhyay, B Shekarriz, J A Nemeth, et al.Gynecologic Oncology|September 5, 2001
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancerE Lengyel, B Schmalfeldt, E Konik, et al.Journal of the National Cancer Institute|June 5, 1991
Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with MatrigelR Fridman, M C Kibbey, L S Royce, et al.Internal Medicine Journal|February 8, 2024
Sex differences in stroke reperfusion therapy in Aotearoa (New Zealand)Michal R Fridman, Stephanie G Thompson, Alicia Tyson, et al.The Journal of Biological Chemistry|August 5, 1992
Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regionsR Fridman, T R Fuerst, R E Bird, et al.Pageof 8